These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 24187824)

  • 1. [Recent progress in vaccines against nicotine addiction].
    Wang GB; Zhu CJ
    Yao Xue Xue Bao; 2013 Aug; 48(8):1189-94. PubMed ID: 24187824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nicotine vaccines to treat tobacco dependence.
    Goniewicz ML; Delijewski M
    Hum Vaccin Immunother; 2013 Jan; 9(1):13-25. PubMed ID: 23108361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicotine vaccines.
    Fahim RE; Kessler PD; Fuller SA; Kalnik MW
    CNS Neurol Disord Drug Targets; 2011 Dec; 10(8):905-15. PubMed ID: 22229310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic vaccines for nicotine dependence.
    Maurer P; Bachmann MF
    Curr Opin Mol Ther; 2006 Feb; 8(1):11-6. PubMed ID: 16506520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expecting the antinicotine vaccine].
    Didilescu C
    Pneumologia; 2009; 58(3):177-8. PubMed ID: 19817315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination against nicotine: an emerging therapy for tobacco dependence.
    Maurer P; Bachmann MF
    Expert Opin Investig Drugs; 2007 Nov; 16(11):1775-83. PubMed ID: 17970637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting nicotine addiction: the possibility of a therapeutic vaccine.
    Escobar-Chávez JJ; Domínguez-Delgado CL; Rodríguez-Cruz IM
    Drug Des Devel Ther; 2011; 5():211-24. PubMed ID: 21607018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic vaccines against tobacco addiction.
    Fahim RE; Kessler PD; Kalnik MW
    Expert Rev Vaccines; 2013 Mar; 12(3):333-42. PubMed ID: 23496672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and immunogenicity of a nicotine conjugate vaccine in current smokers.
    Hatsukami DK; Rennard S; Jorenby D; Fiore M; Koopmeiners J; de Vos A; Horwith G; Pentel PR
    Clin Pharmacol Ther; 2005 Nov; 78(5):456-67. PubMed ID: 16321612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotine vaccines to assist with smoking cessation: current status of research.
    Raupach T; Hoogsteder PH; Onno van Schayck CP
    Drugs; 2012 Mar; 72(4):e1-16. PubMed ID: 22356293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The vaccine against nicotine--the future for smoking cessation?].
    Mihăltan F
    Pneumologia; 2007; 56(2):101-3. PubMed ID: 18019757
    [No Abstract]   [Full Text] [Related]  

  • 12. Probing the protective effects of a conformationally constrained nicotine vaccine.
    Moreno AY; Azar MR; Koob GF; Janda KD
    Vaccine; 2012 Oct; 30(47):6665-70. PubMed ID: 22963803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment and prevention of tobacco addiction. Antinicotinic vaccine].
    Fernández PL
    An R Acad Nac Med (Madr); 2012; 129(1):295-304; discussion 304-6. PubMed ID: 24294730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nicotine vaccines for smoking cessation.
    Murtagh J; Foerster V
    Issues Emerg Health Technol; 2007 Sep; (103):1-4. PubMed ID: 17896445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New prospects of nicotine dependence treatment--vaccines].
    Goniewicz ML; Koszowski B; Czogała J; Zymełka A
    Przegl Lek; 2006; 63(10):1114-8. PubMed ID: 17288232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current status of immunologic approaches to treating tobacco dependence: vaccines and nicotine-specific antibodies.
    LeSage MG; Keyler DE; Pentel PR
    AAPS J; 2006 Feb; 8(1):E65-75. PubMed ID: 16584135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nicotine conjugate vaccine as a novel approach to smoking cessation.
    Ottney AR
    Pharmacotherapy; 2011 Jul; 31(7):703-13. PubMed ID: 21923458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of a nicotine vaccine on nicotine binding to β2*-nicotinic acetylcholine receptors in vivo in human tobacco smokers.
    Esterlis I; Hannestad JO; Perkins E; Bois F; D'Souza DC; Tyndale RF; Seibyl JP; Hatsukami DM; Cosgrove KP; O'Malley SS
    Am J Psychiatry; 2013 Apr; 170(4):399-407. PubMed ID: 23429725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immunogenicity and safety of a nicotine vaccine in smokers and nonsmokers: results of a randomized, placebo-controlled phase 1/2 trial.
    Wagena EJ; de Vos A; Horwith G; van Schayck CP
    Nicotine Tob Res; 2008 Jan; 10(1):213-8. PubMed ID: 18188762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccines against nicotine: how effective are they likely to be in preventing smoking?
    Vocci FJ; Chiang CN
    CNS Drugs; 2001; 15(7):505-14. PubMed ID: 11510621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.